A randomized, double-blind, placebo-controlled, dose-ranging study using Genz-644470 and sevelamer carbonate in hyperphosphatemic chronic kidney disease patients on hemodialysis

por Moustafa, Moustafa, Lehrner, Lawrence, Al-Saghir, Fahd, Smith, Mark, Goyal, Sunita, Dillon, Maureen, Hunter, John, Holmes-Farley, Randy
Publicado 2014